Surgery Partners Inc (SGRY): Hedge Fund Ownership & Smart Money Signals (Q1 2026)

Q: Is it too late to buy Surgery Partners Inc (SGRY) following the 2026 Q1 hedge fund 13F filings?

As of today, SGRY has moved +9.7% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of +3.7%. Since the quarter end (March 31, 2026), SGRY gained +28.4% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Surgery Partners Inc (SGRY)

179 + Investors. Track Smart Money conviction in SGRY. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — SGRY

Based on 179 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 2 quarters in a row

last 6Q

For 2 consecutive quarters, more hedge funds reduced or closed their SGRY positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

📊

High ownership — 90% of 3.0Y peak

90% of all-time peak

179 funds currently hold this stock — 90% of the 3.0-year high of 200 funds (reached 2025 Q1). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.

📉

Outflows — 10% fewer funds vs a year ago

fund count last 6Q

21 fewer hedge funds hold SGRY compared to a year ago (-10% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.

🟡

Slight buying edge — 55% buying

100 buying82 selling

Last quarter: 100 funds bought or added vs 82 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

➡️

Steady new buyers — ~31 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 39 → 34 → 35 → 31. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔒

56% of holders stayed for 2+ years

■ 56% conviction (2yr+) ■ 24% medium ■ 20% new

100 out of 179 hedge funds have held SGRY for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💎

Buying through price weakness — shares +3%, value -22%

Value

-22%

+2%

Last quarter: funds added +3% more shares while total portfolio value only changed -22%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

➡️

Steady discovery — ~31 new funds/quarter

60 → 39 → 34 → 35 → 31 new funds/Q

New funds entering each quarter: 39 → 34 → 35 → 31. Consistent flow of new institutional buyers without clear acceleration or slowdown.

🏛️

Deep conviction — 64% of holders stayed 2+ years

■ 64% veterans ■ 12% 1-2yr ■ 24% new

Of 189 current holders: 121 (64%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.

✅

Strong quality — 34% AUM from major funds

34% from top-100 AUM funds

45 of 179 holders rank in the top 100 by AUM, accounting for 34% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

3.0

out of 10

Low Exit Risk

Exit risk score 3.0/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	179	181	-1.1%
13F Shares	162M	158M	2.51%
Total Value	$1.90B	$2.44B	-22.1%
New Positions	31	35	-4
Increased Positions	67	56	+11
Closed Positions	33	50	-17
Reduced Positions	46	67	-21
Total Calls	6	4	50.0%
Total Puts	5	7	-28.57%
PUT/CALL Ratio	0.83	1.75	Neutral

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

179

181

-1.1%

13F Shares

162M

158M

2.51%

Total Value

$1.90B

$2.44B

-22.1%

New Positions

-4

Increased Positions

+11

Closed Positions

-17

Reduced Positions

-21

Total Calls

50.0%

Total Puts

-28.57%

PUT/CALL Ratio

0.83

1.75

Neutral

Institutional Holders (2026 Q1)

179 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in SGRY. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 SGRY holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	King Street Capital Management, L.P.	37.17%	10,229,730	$121.9M
2	Varde Management, L.P.	18.26%	755,438	$9.0M
3	Bain Capital Investors LLC	18.22%	49,946,972	$595.4M
4	Sea Cliff Partners Management, LP	6.40%	1,039,799	$12.4M
5	Whitefort Capital Management, LP	3.20%	911,136	$10.9M
6	One68 Global Capital, LLC	1.74%	45,000	$536K
7	Dimension Capital Management LLC	0.89%	530,606	$6.3M
8	Pentwater Capital Management LP	0.78%	12,655,000	$150.8M
9	Pier Capital, LLC	0.63%	322,246	$3.8M
10	Irenic Capital Management LP	0.55%	711,000	$8.5M
11	Davidson Kempner Capital Management LP	0.54%	3,336,464	$39.8M
12	Glenview Capital Management, LLC	0.54%	1,800,000	$21.5M
13	Olympiad Research LP	0.40%	10,912	$130K
14	Tranquility Partners, LLC	0.31%	68,062	$811K
15	Sirios Capital Management L P	0.29%	199,054	$2.4M
16	Quinn Opportunity Partners LLC	0.26%	413,860	$4.9M
17	Clearline Capital LP	0.19%	314,144	$3.7M
18	Marble Bar Asset Management LLP	0.19%	15,828	$189K
19	Rock Springs Capital Management LP	0.15%	208,000	$2.5M
20	Crawford Fund Management, LLC	0.14%	63,000	$751K
21	Camelot Portfolios, LLC	0.12%	13,732	$164K
22	VARCOV Co.	0.12%	26,187	$312K
23	Dark Forest Capital Management LP	0.10%	90,198	$1.1M
24	Janus Henderson Group plc	0.08%	13,540,385	$161.4M
25	Twin Securities, Inc.	0.06%	10,025	$119K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Surgery Partners Inc (SGRY)

What does the Smart Money Trend signal show for SGRY?

Selling streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds reduced or closed their SGRY positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for SGRY?

Slight buying edge — 55% buying: Last quarter: 100 funds bought or added vs 82 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for SGRY holders?

Strong quality — 34% AUM from major funds: 45 of 179 holders rank in the top 100 by AUM, accounting for 34% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held SGRY?

56% of holders stayed for 2+ years: 100 out of 179 hedge funds have held SGRY for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Surgery Partners Inc (SGRY) following the 2026 Q1 hedge fund 13F filings?

As of today, SGRY has moved +9.7% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of +3.7%. Since the quarter end (March 31, 2026), SGRY has gained +28.4% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Surgery Partners Inc (SGRY)

Smart Money Signals — SGRY

Selling streak — 2 quarters in a row

High ownership — 90% of 3.0Y peak

Outflows — 10% fewer funds vs a year ago

Slight buying edge — 55% buying

Steady new buyers — ~31 new funds per quarter

56% of holders stayed for 2+ years

Buying through price weakness — shares +3%, value -22%

Steady discovery — ~31 new funds/quarter

Deep conviction — 64% of holders stayed 2+ years

Strong quality — 34% AUM from major funds

Institutional Sentiment Summary — SGRY

Hedge Fund Ownership: SGRY

Market Analysis: SGRY

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: SGRY

Is It Too Late to Buy Surgery Partners Inc (SGRY) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: SGRY

Statistics: SGRY

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — Surgery Partners Inc (SGRY)

Welcome to 13Foresight!